1	Thapsigargin	thapsigargin	_	_	_	_	_	_	_
2	induces	induce	_	_	_	_	_	_	_
3	IL-2	il-2	_	_	_	_	_	_	_
4	receptor	receptor	_	_	_	_	_	_	_
5	alpha-chain	alpha-chain	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	human	human	_	_	_	_	_	_	_
8	peripheral	peripheral	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	Jurkat	jurkat	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	via	via	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	protein	protein	_	_	_	_	_	_	_
16	kinase	kinase	_	_	_	_	_	_	_
17	C-independent	c-independent	_	_	_	_	_	_	_
18	mechanism	mechanism	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Thapsigargin	Thapsigargin	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	TG	TG	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	an	an	_	_	_	_	_	_	_
7	inhibitor	inhibitor	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	Ca(2+)-ATPase	Ca(2+)-ATPase	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	depletes	deplete	_	_	_	_	_	_	_
12	intracellular	intracellular	_	_	_	_	_	_	_
13	Ca2+	ca2+	_	_	_	_	_	_	_
14	stores	store	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	induces	induce	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	sustained	sustained	_	_	_	_	_	_	_
19	Ca2+	ca2+	_	_	_	_	_	_	_
20	influx	influx	_	_	_	_	_	_	_
21	without	without	_	_	_	_	_	_	_
22	altering	alter	_	_	_	_	_	_	_
23	phosphatidyl	phosphatidyl	_	_	_	_	_	_	_
24	inositol	inositol	_	_	_	_	_	_	_
25	levels	level	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	TG	TG	_	_	_	_	_	_	_
2	plus	plus	_	_	_	_	_	_	_
3	phorbol	phorbol	_	_	_	_	_	_	_
4	myristate	myristate	_	_	_	_	_	_	_
5	acetate	acetate	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	PMA	PMA	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	but	but	_	_	_	_	_	_	_
10	not	not	_	_	_	_	_	_	_
11	TG	tg	_	_	_	_	_	_	_
12	alone	alone	_	_	_	_	_	_	_
13	induced	induce	_	_	_	_	_	_	_
14	IL-2	il-2	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	Jurkat	Jurkat	_	_	_	_	_	_	_
17	T	t	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	suggesting	suggest	_	_	_	_	_	_	_
21	that	that	_	_	_	_	_	_	_
22	TG	TG	_	_	_	_	_	_	_
23	had	have	_	_	_	_	_	_	_
24	no	no	_	_	_	_	_	_	_
25	effect	effect	_	_	_	_	_	_	_
26	on	on	_	_	_	_	_	_	_
27	protein	protein	_	_	_	_	_	_	_
28	kinase	kinase	_	_	_	_	_	_	_
29	C	C	_	_	_	_	_	_	_
30	(	(	_	_	_	_	_	_	_
31	PKC	PKC	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	TG	TG	_	_	_	_	_	_	_
4	induced	induce	_	_	_	_	_	_	_
5	increases	increase	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	IL-2R	IL-2R	_	_	_	_	_	_	_
8	alpha	alpha	_	_	_	_	_	_	_
9	protein	protein	_	_	_	_	_	_	_
10	as	as	_	_	_	_	_	_	_
11	well	well	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	IL-2R	IL-2R	_	_	_	_	_	_	_
14	alpha	alpha	_	_	_	_	_	_	_
15	mRNA	mrna	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	Jurkat	Jurkat	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	a	a	_	_	_	_	_	_	_
22	dose-dependent	dose-dependent	_	_	_	_	_	_	_
23	manner	manner	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	similar	similar	_	_	_	_	_	_	_
3	increase	increase	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	IL-2R	IL-2R	_	_	_	_	_	_	_
6	alpha	alpha	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	TG	TG	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	also	also	_	_	_	_	_	_	_
11	observed	observe	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	human	human	_	_	_	_	_	_	_
14	peripheral	peripheral	_	_	_	_	_	_	_
15	T	t	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Further	further	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	like	like	_	_	_	_	_	_	_
4	PMA	PMA	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	TG	TG	_	_	_	_	_	_	_
7	markedly	markedly	_	_	_	_	_	_	_
8	induced	induce	_	_	_	_	_	_	_
9	NF	NF	_	_	_	_	_	_	_
10	kappa	kappa	_	_	_	_	_	_	_
11	B	B	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	Jurkat	Jurkat	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	TG	TG	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	PMA	PMA	_	_	_	_	_	_	_
6	exhibited	exhibit	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	synergistic	synergistic	_	_	_	_	_	_	_
9	action	action	_	_	_	_	_	_	_
10	on	on	_	_	_	_	_	_	_
11	IL-2R	IL-2R	_	_	_	_	_	_	_
12	alpha	alpha	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	suggesting	suggest	_	_	_	_	_	_	_
16	that	that	_	_	_	_	_	_	_
17	TG	TG	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	PMA	PMA	_	_	_	_	_	_	_
20	induce	induce	_	_	_	_	_	_	_
21	IL-2R	il-2r	_	_	_	_	_	_	_
22	alpha	alpha	_	_	_	_	_	_	_
23	through	through	_	_	_	_	_	_	_
24	distinct	distinct	_	_	_	_	_	_	_
25	pathways	pathway	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	PMA-	PMA-	_	_	_	_	_	_	_
2	but	but	_	_	_	_	_	_	_
3	not	not	_	_	_	_	_	_	_
4	TG-induced	tg-induced	_	_	_	_	_	_	_
5	IL-2R	IL-2R	_	_	_	_	_	_	_
6	alpha	alpha	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	inhibited	inhibit	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	PKC	PKC	_	_	_	_	_	_	_
12	inhibitor	inhibitor	_	_	_	_	_	_	_
13	H7	h7	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	whereas	whereas	_	_	_	_	_	_	_
16	TG-	TG-	_	_	_	_	_	_	_
17	but	but	_	_	_	_	_	_	_
18	not	not	_	_	_	_	_	_	_
19	PMA-induced	pma-induced	_	_	_	_	_	_	_
20	IL-2R	IL-2R	_	_	_	_	_	_	_
21	alpha	alpha	_	_	_	_	_	_	_
22	was	be	_	_	_	_	_	_	_
23	inhibited	inhibit	_	_	_	_	_	_	_
24	by	by	_	_	_	_	_	_	_
25	cholera	cholera	_	_	_	_	_	_	_
26	toxin	toxin	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	forskolin	forskolin	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	1,9-dideoxy	1,9-dideoxy	_	_	_	_	_	_	_
31	forskolin	forskolin	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	toto	toto	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	these	these	_	_	_	_	_	_	_
5	results	result	_	_	_	_	_	_	_
6	suggest	suggest	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	TG	TG	_	_	_	_	_	_	_
9	induces	induce	_	_	_	_	_	_	_
10	IL-2R	il-2r	_	_	_	_	_	_	_
11	alpha	alpha	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	human	human	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	through	through	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	PKC-independent	pkc-independent	_	_	_	_	_	_	_
19	pathway	pathway	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

